Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | erb-b2 receptor tyrosine kinase 2 | Starlite/ChEMBL | References |
Homo sapiens | epidermal growth factor receptor | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Casein kinase II, alpha chain | 0.0286 | 0.7017 | 0.6973 |
Echinococcus granulosus | melanoma receptor tyrosine protein kinase | 0.0194 | 0.3299 | 0.32 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0286 | 0.7017 | 0.5 |
Onchocerca volvulus | 0.0239 | 0.5116 | 0.5 | |
Echinococcus granulosus | casein kinase ii subunit alpha | 0.0286 | 0.7017 | 0.6973 |
Plasmodium falciparum | casein kinase 2, alpha subunit | 0.0286 | 0.7017 | 0.5 |
Schistosoma mansoni | tyrosine kinase | 0.0194 | 0.3299 | 0.32 |
Giardia lamblia | Kinase, CMGC CK2 | 0.0286 | 0.7017 | 0.5 |
Trypanosoma brucei | Casein kinase II | 0.0286 | 0.7017 | 0.5 |
Plasmodium vivax | casein kinase 2, alpha subunit, putative | 0.0286 | 0.7017 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0286 | 0.7017 | 0.5 |
Schistosoma mansoni | tyrosine kinase | 0.0194 | 0.3299 | 0.32 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0286 | 0.7017 | 0.5 |
Schistosoma mansoni | tyrosine kinase | 0.0191 | 0.3217 | 0.3117 |
Echinococcus multilocularis | epidermal growth factor receptor | 0.036 | 1 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0286 | 0.7017 | 0.5 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0286 | 0.7017 | 0.5 |
Schistosoma mansoni | tyrosine kinase | 0.036 | 1 | 1 |
Loa Loa (eye worm) | CMGC/CK2 protein kinase | 0.0286 | 0.7017 | 0.6973 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0286 | 0.7017 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0286 | 0.7017 | 0.5 |
Echinococcus multilocularis | casein kinase ii subunit alpha | 0.0286 | 0.7017 | 0.7017 |
Echinococcus granulosus | epidermal growth factor receptor | 0.0194 | 0.3299 | 0.32 |
Schistosoma mansoni | tyrosine kinase | 0.0191 | 0.3217 | 0.3117 |
Entamoeba histolytica | casein kinase, putative | 0.0286 | 0.7017 | 0.5 |
Schistosoma mansoni | protein kinase | 0.0286 | 0.7017 | 0.6973 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0286 | 0.7017 | 0.5 |
Toxoplasma gondii | CMGC kinase, CK2 family | 0.0286 | 0.7017 | 0.5 |
Echinococcus multilocularis | insulin growth factor 1 receptor beta | 0.0115 | 0.0145 | 0.0145 |
Echinococcus multilocularis | insulin receptor | 0.0115 | 0.0145 | 0.0145 |
Echinococcus granulosus | epidermal growth factor receptor | 0.036 | 1 | 1 |
Echinococcus multilocularis | epidermal growth factor receptor | 0.0194 | 0.3299 | 0.3299 |
Schistosoma mansoni | tyrosine kinase | 0.0191 | 0.3217 | 0.3117 |
Plasmodium vivax | unspecified product | 0.0286 | 0.7017 | 0.5 |
Loa Loa (eye worm) | TK/EGFR protein kinase | 0.036 | 1 | 1 |
Loa Loa (eye worm) | CAMK/CAMKL/PASK protein kinase | 0.0239 | 0.5116 | 0.5044 |
Leishmania major | casein kinase II, putative | 0.0286 | 0.7017 | 0.5 |
Trypanosoma cruzi | casein kinase II, putative | 0.0286 | 0.7017 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (ADMET) | Toxicity in BALB/c athymic mouse xenografted with human SKOV3 cells assessed as weight loss at 200 mg/kg, po qd after 4 days | ChEMBL. | 24121234 | |
Activity (ADMET) | Toxicity in BALB/c athymic mouse xenografted with human NCI-N87 cells assessed as weight loss at 200 mg/kg, po qd after 4 days | ChEMBL. | 24121234 | |
Activity (ADMET) | Toxicity in BALB/c athymic mouse xenografted with human NCI-N87 cells assessed as bloody stool at 200 mg/kg, po qd after 4 days | ChEMBL. | 24121234 | |
Activity (ADMET) | Toxicity in BALB/c athymic mouse xenografted with human NCI-N87 cells assessed as hematuria at 200 mg/kg, po qd after 4 days | ChEMBL. | 24121234 | |
Activity (ADMET) | Toxicity in BALB/c athymic mouse xenografted with human SKOV3 cells assessed as bloody stool at 200 mg/kg, po qd after 4 days | ChEMBL. | 24121234 | |
Activity (ADMET) | Toxicity in BALB/c athymic mouse xenografted with human SKOV3 cells assessed as hematuria at 200 mg/kg, po qd after 4 days | ChEMBL. | 24121234 | |
IC50 (binding) | = 15.9 nM | Inhibition of HER-2 (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry | ChEMBL. | 24121234 |
IC50 (binding) | = 18.7 nM | Inhibition of EGFR (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry | ChEMBL. | 24121234 |
IC50 (functional) | = 27.4 nM | Cytotoxicity against human BT474 cells after 72 hrs by SRB assay | ChEMBL. | 24121234 |
TGI (functional) | = 35.8 % | Antitumor activity against human SKOV3 cells xenografted in BALB/c athymic mouse assessed as tumor regression at 200 mg/kg, po qd after 28 days relative to vehicle-treated control | ChEMBL. | 24121234 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 24121234 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.